| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000093876 |
| P356 | DOI | 10.1007/S11894-015-0471-Z |
| P698 | PubMed publication ID | 26449614 |
| P2093 | author name string | Brooks D Cash | |
| Hani Sbahi | |||
| P2860 | cites work | The impact of anorectal biofeedback therapy on the quality of life of patients with dyssynergic defecation | Q43331456 |
| Two randomized trials of linaclotide for chronic constipation | Q43332645 | ||
| Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. | Q43332828 | ||
| Obstructive defecation: a failure of rectoanal coordination | Q43333469 | ||
| Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey | Q43351260 | ||
| Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation | Q43352896 | ||
| Plecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single doses | Q43358120 | ||
| Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study | Q44338607 | ||
| Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation | Q46966647 | ||
| Clinical features' diagnostics and treatment of Hirschsprung's disease in adults | Q47269729 | ||
| Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation | Q48067082 | ||
| Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. | Q51310014 | ||
| Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. | Q51368980 | ||
| [Clinical benefits after soluble dietary fiber supplementation: a randomized clinical trial in adults with slow-transit constipation]. | Q53627879 | ||
| Fluid loading of the human colon: effects on segmental transit and stool composition | Q70495705 | ||
| Decreased substance P levels in rectal biopsies from patients with slow transit constipation | Q71939208 | ||
| Severe slow-transit constipation following radical hysterectomy | Q72253278 | ||
| Motor and sensory function of the rectum in different subtypes of constipation | Q73539723 | ||
| Gastric emptying in patients with constipation following childbirth and due to idiopathic slow transit | Q73649195 | ||
| Physiology of refractory chronic constipation | Q74623777 | ||
| Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon | Q78439505 | ||
| Chronic constipation | Q79107898 | ||
| An evidence-based approach to the management of chronic constipation in North America | Q80355694 | ||
| Rectal hyposensitivity: pathophysiological mechanisms | Q82938355 | ||
| Defecography in normal volunteers: results and implications | Q24548166 | ||
| Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis | Q24635181 | ||
| Treatment for constipation: new and old pharmacological strategies | Q27027346 | ||
| Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women | Q28198822 | ||
| Stool form scale as a useful guide to intestinal transit time | Q28249217 | ||
| Myths and misconceptions about chronic constipation | Q28302906 | ||
| Functional bowel disorders | Q29620328 | ||
| Decreased interstitial cell of cajal volume in patients with slow-transit constipation | Q30829072 | ||
| A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation | Q33436983 | ||
| A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications | Q33438496 | ||
| Methylnaltrexone for opioid-induced constipation in advanced illness | Q33439945 | ||
| Efficacy and safety of lubiprostone in patients with chronic constipation | Q34088270 | ||
| Dyssynergic defecation | Q34274703 | ||
| American Gastroenterological Association technical review on constipation | Q34319119 | ||
| Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. | Q34425360 | ||
| Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. | Q34433417 | ||
| The recto-anal inhibitory reflex: abnormal response in diabetics suggests an intrinsic neuroenteropathy | Q34485326 | ||
| Functional anorectal disorders | Q34522472 | ||
| Effect of changing transit time on colonic microbial metabolism in man. | Q34527412 | ||
| Severe chronic constipation of young women: 'idiopathic slow transit constipation' | Q34528432 | ||
| Hirschsprung's disease and idiopathic megacolon in adults and adolescents | Q34529608 | ||
| Diagnostic testing in patients with chronic constipation. | Q34570820 | ||
| Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation | Q34609605 | ||
| Clinical utility of colonic and anorectal manometry in chronic constipation | Q34622130 | ||
| What is necessary to diagnose constipation? | Q34627402 | ||
| Oral bisacodyl is effective and well-tolerated in patients with chronic constipation | Q34627970 | ||
| A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain | Q34805216 | ||
| Lubiprostone in constipation: clinical evidence and place in therapy | Q35091370 | ||
| Diagnosis and treatment of chronic constipation--a European perspective | Q35207439 | ||
| A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation | Q35286303 | ||
| Epidemiology and burden of chronic constipation | Q35506103 | ||
| Current treatment options for chronic constipation. | Q35796926 | ||
| The health-related quality of life and economic burden of constipation | Q36128773 | ||
| Clinical utility of diagnostic tests for constipation in adults: a systematic review | Q36177712 | ||
| Measurement of gastrointestinal transit | Q36178630 | ||
| A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation | Q36417684 | ||
| Dual activation of CFTR and CLCN2 by lubiprostone in murine nasal epithelia | Q36699974 | ||
| A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America | Q37267832 | ||
| Constipation is not associated with an increased rate of findings on colonoscopy: results from a national endoscopy consortium | Q37354957 | ||
| Treatment of chronic constipation: current pharmacologic approaches and future directions | Q37367033 | ||
| Constipation in old age. | Q37639686 | ||
| Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation | Q37711191 | ||
| Medical and surgical management of pelvic floor disorders affecting defecation | Q37724871 | ||
| Diagnosing irritable bowel syndrome: a changing clinical paradigm | Q37836334 | ||
| Epidemiology of constipation in children and adults: a systematic review | Q37850555 | ||
| Current and future therapies for chronic constipation | Q37850564 | ||
| Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis | Q37878858 | ||
| A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. | Q38003558 | ||
| Chronic constipation: a critical review | Q38103650 | ||
| Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis | Q38113454 | ||
| The role of endoscopy in the management of constipation | Q38242553 | ||
| Constipation: pathophysiology and management | Q38267938 | ||
| Naloxegol , a new drug for the treatment of opioid-induced constipation | Q38286331 | ||
| Chronic severe constipation: current pathophysiological aspects, new diagnostic approaches, and therapeutic options | Q38335422 | ||
| Efficacy of linaclotide for patients with chronic constipation | Q39293456 | ||
| Pilot study on the effect of linaclotide in patients with chronic constipation | Q39310204 | ||
| Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies. | Q39311968 | ||
| Chronic constipation: a survey of the patient perspective | Q39339484 | ||
| Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation | Q39339800 | ||
| Overnight efficacy of polyethylene glycol laxative | Q39404856 | ||
| Digital rectal examination is a useful tool for identifying patients with dyssynergia | Q39943065 | ||
| Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation | Q41672265 | ||
| Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation | Q42923520 | ||
| Methylnaltrexone and gastrointestinal perforation | Q42974706 | ||
| Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation | Q43152297 | ||
| Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study | Q43329442 | ||
| Constipation: a different entity for patients and doctors | Q43330061 | ||
| Clinical response to dietary fiber treatment of chronic constipation. | Q43331057 | ||
| P433 | issue | 12 | |
| P921 | main subject | constipation | Q178436 |
| P304 | page(s) | 47 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Current gastroenterology reports | Q26842032 |
| P1476 | title | Chronic Constipation: a Review of Current Literature | |
| P478 | volume | 17 |
| Q93127193 | A Randomized Controlled Trial on the Effects of Electromyographic Biofeedback on Quality of Life and Bowel Symptoms in Elderly Women With Dyssynergic Defecation |
| Q90263661 | Colonic Motility and Jejunal Vagal Afferent Firing Rates Are Decreased in Aged Adult Male Mice and Can Be Restored by an Aminosterol |
| Q48248529 | Constipation management in people with intellectual disability: A systematic review |
| Q64079654 | High Prevalence of Slow Transit Constipation in Patients With Gastroparesis |
| Q91716327 | The effect and safety of acupuncture on patients with functional constipation: Protocol for a systematic review and meta-analysis of high quality RCTs |
Search more.